Charles Kummeth
Chairman of the Board of DirectorsatBIO-TECHNE· In proxies 2021–2025
Pay in FY2023+99% from the year before · BIO-TECHNE stock -5.6% the same year
Charles Kummeth was paid $30.6M in FY2023 (Jun), up 99%. BIO-TECHNE stock fell 5.6% that year.
Pay$100 in the stock at the end of FY20 → $125
Experience
- Quantum-SiPublic company · 1 yr
- Chairman of the Board of Directors2025 – Present · 1 yrNo stock prices for these years
- BIO-TECHNEPublic company · 5 yr
- Former President and CEO2021 – Present · 5 yrStock in role +12%
- Orthofix MedicalPublic company · 3 yr
- Director2023 – Present · 3 yrNo stock prices for these years
- Gentherm, Inc.Public company · 8 yr
- Director2018 – Present · 8 yrNo stock prices for these years
Roles come from the proxy statements of each company.
Boards1
- BIO-TECHNEDirector · 10 yr on the boardIndependent—Paid as an executive
Board seats come from each company's latest proxy statement.
Activity
Two people shown as one, or a wrong number?